# Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III

> **NCT04918108** · — · COMPLETED · sponsor: **Nanjing Medical University** · enrollment: 2000 (actual)

## Conditions studied

- Aortic Dissection

## Interventions

- **BIOLOGICAL:** inflammatory response

## Key facts

- **NCT ID:** NCT04918108
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918108, "Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04918108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*